{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:48:28Z","timestamp":1783579708988,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Guillain-Barr\u00e9 Syndrome (GBS) is an immune-mediated peripheral neuropathy. Clinical features and outcomes in children differ from adults. Currently, there is no prognostic model to predict outcomes in children and existing models for adults are not suitable.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>To identify factors that are associated with outcomes and develop clinical model to predict time to independent walking in children with GBS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Between 2005 and 2018, 41 patients with GBS were identified by retrospective chart review. Factors associated with independent walking were analyzed with the Kaplan\u2013Meier method. A prediction model was developed based on regression coefficients from Cox\u2019s proportional hazard model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The disability score at maximum weakness and nerve conduction study results were associated with independent walking and included in the model. Scores range from 0 to 5. A score of 5 predicts 34 days to independent walking while a score of 0 predicts 5 months (mean 158 days, <jats:italic>p<\/jats:italic>\u2009=\u20090.008).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This scoring system for pediatric patients provides predicts the time needed to achieve independent walking, an important milestone of recovery for communication with parents, and to assist clinicians to optimize treatment. Further studies of predictive factors and external validation are needed to improve precision of the model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Impact<\/jats:title>\n                <jats:p><jats:list list-type=\"bullet\">\n                  <jats:list-item>\n                    <jats:p>This is the first study to create a prognostic scoring system for individual outcomes in children with GBS.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>A clinical prognostic model can predict time to achieve independent walking in individual pediatric patients with GBS.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>This model can assist clinicians to optimize treatment and guide decisions on rehabilitation to prevent long-term disability.<\/jats:p>\n                  <\/jats:list-item>\n                <\/jats:list><\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41390-021-01919-3","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T14:04:52Z","timestamp":1644933892000},"page":"1417-1422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prognostic model for time to achieve independent walking in children with Guillain-Barr\u00e9 syndrome"],"prefix":"10.1038","volume":"92","author":[{"given":"Peerada","family":"Chaweekulrat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4557-0387","authenticated-orcid":false,"given":"Oranee","family":"Sanmaneechai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,15]]},"reference":[{"key":"1919_CR1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","volume":"388","author":"HJ Willison","year":"2016","unstructured":"Willison, H. J., Jacobs, B. C. & van Doorn, P. A. Guillain-Barr\u00e9 Syndrome. Lancet 388, 717\u2013727 (2016).","journal-title":"Lancet"},{"key":"1919_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1177\/088307380001500308","volume":"15","author":"AK Asbury","year":"2000","unstructured":"Asbury, A. K. New Concepts of Guillain-Barr\u00e9 Syndrome. J. Child Neurol. 15, 183\u2013191 (2000).","journal-title":"J. Child Neurol."},{"key":"1919_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1055\/s-2007-981686","volume":"38","author":"R Korinthenberg","year":"2007","unstructured":"Korinthenberg, R., Schessl, J. & Kirschner, J. Clinical Presentation and Course of Childhood Guillain-Barr\u00e9 Syndrome: a Prospective Multicentre Study. Neuropediatrics 38, 10\u201317 (2007).","journal-title":"Neuropediatrics"},{"key":"1919_CR4","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/1531-8249(199911)46:5<701::AID-ANA4>3.0.CO;2-7","volume":"46","author":"G Paradiso","year":"1999","unstructured":"Paradiso, G., Tripoli, J., Galicchio, S. & Fejerman, N. Epidemiological, Clinical, and Electrodiagnostic Findings in Childhood Guillain-Barr\u00e9 Syndrome: a Reappraisal. Ann. Neurol. 46, 701\u2013707 (1999).","journal-title":"Ann. Neurol."},{"key":"1919_CR5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ncl.2013.01.005","volume":"31","author":"MM Dimachkie","year":"2013","unstructured":"Dimachkie, M. M. & Barohn, R. J. Guillain-Barr\u00e9 Syndrome and Variants. Neurol. Clin. 31, 491\u2013510 (2013).","journal-title":"Neurol. Clin."},{"key":"1919_CR6","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000184748","volume":"32","author":"A McGrogan","year":"2009","unstructured":"McGrogan, A., Madle, G. C., Seaman, H. E. & de Vries, C. S. The Epidemiology of Guillain-Barr\u00e9 Syndrome Worldwide. A Systematic Literature Review. Neuroepidemiology 32, 150\u2013163 (2009).","journal-title":"Neuroepidemiology"},{"key":"1919_CR7","first-page":"333","volume":"82","author":"M Barzegar","year":"2017","unstructured":"Barzegar, M. et al. Predictive Factors for Achieving Independent Walking in Children with Guillain-Barre Syndromese Y. be Restrict. study aPediatr Res 82, 333\u2013339 (2017).","journal-title":"be Restrict. study aPediatr Res"},{"key":"1919_CR8","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1136\/jnnp-2011-301882","volume":"83","author":"YA Rajabally","year":"2012","unstructured":"Rajabally, Y. A. & Uncini, A. Outcome and Its Predictors in Guillain-Barre Syndrome. J. Neurol. Neurosurg. Psychiatry 83, 711\u2013718 (2012).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1919_CR9","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S1474-4422(07)70130-8","volume":"6","author":"R van Koningsveld","year":"2007","unstructured":"van Koningsveld, R. et al. A Clinical Prognostic Scoring System for Guillain-Barr\u00e9 Syndrome. Lancet Neurol. 6, 589\u2013594 (2007).","journal-title":"Lancet Neurol."},{"key":"1919_CR10","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1212\/WNL.0b013e3182104407","volume":"76","author":"C Walgaard","year":"2011","unstructured":"Walgaard, C. et al. Early Recognition of Poor Prognosis in Guillain-Barre Syndrome. Neurology 76, 968\u2013975 (2011).","journal-title":"Neurology"},{"key":"1919_CR11","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s12098-009-0125-y","volume":"76","author":"V Kalra","year":"2009","unstructured":"Kalra, V. et al. Outcome in Childhood Guillain-Barr\u00e9 Syndrome. Indian J. Pediatr. 76, 795\u2013799 (2009).","journal-title":"Indian J. Pediatr."},{"key":"1919_CR12","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1177\/088307380101600703","volume":"16","author":"Z Ammache","year":"2001","unstructured":"Ammache, Z., Afifi, A. K., Brown, C. K. & Kimura, J. Childhood Guillain-Barr\u00e9 Syndrome: Clinical and Electrophysiologic Features Predictive of Outcome. J. Child Neurol. 16, 477\u2013483 (2001).","journal-title":"J. Child Neurol."},{"issue":"Suppl 6.","key":"1919_CR13","first-page":"S101","volume":"97","author":"S Sri-udomkajorn","year":"2014","unstructured":"Sri-udomkajorn, S. & Suwannachote, S. Demographics, Clinical Features, Outcome and Prognostic Factors of Guillain-Barre Syndrome in Thai Children. J. Med Assoc. Thai 97(Suppl 6.), S101\u2013S107 (2014).","journal-title":"J. Med Assoc. Thai"},{"key":"1919_CR14","first-page":"750","volume":"81","author":"A Visudtibhan","year":"1998","unstructured":"Visudtibhan, A., Visudhiphan, P., Chiemchanya, S. & Wiengperm, M. Guillain-Barre Syndrome in Thai Children: Retrospective Analysis of the Clinical and Outcome Prior to Intravenous Immune Globulin Era. J. Med Assoc. Thai 81, 750\u2013756 (1998).","journal-title":"J. Med Assoc. Thai"},{"key":"1919_CR15","first-page":"1150","volume":"93","author":"P Areeyapinan","year":"2010","unstructured":"Areeyapinan, P. & Phanthumchinda, K. Guillain-Barre Syndrome: a Clinical Study in King Chulalongkorn Memorial Hospital. J. Med Assoc. Thai 93, 1150\u20131155 (2010).","journal-title":"J. Med Assoc. Thai"},{"issue":"Suppl.","key":"1919_CR16","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1002\/ana.410270707","volume":"27","author":"AK Asbury","year":"1990","unstructured":"Asbury, A. K. & Cornblath, D. R. Assessment of Current Diagnostic Criteria for Guillain-Barr\u00e9 Syndrome. Ann. Neurol. 27(Suppl.), S21\u2013S24 (1990).","journal-title":"Ann. Neurol."},{"key":"1919_CR17","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","volume":"2","author":"RA Hughes","year":"1978","unstructured":"Hughes, R. A., Newsom-Davis, J. M., Perkin, G. D. & Pierce, J. M. Controlled Trial Prednisolone in Acute Polyneuropathy. Lancet 2, 750\u2013753 (1978).","journal-title":"Lancet"},{"issue":"Suppl.","key":"1919_CR18","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1002\/ana.410270706","volume":"27","author":"DR Cornblath","year":"1990","unstructured":"Cornblath, D. R. Electrophysiology in Guillain-Barr\u00e9 Syndrome. Ann. Neurol. 27(Suppl.), S17\u2013S20 (1990).","journal-title":"Ann. Neurol."},{"key":"1919_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/CND.0000000000000176","volume":"19","author":"K Kulkantrakorn","year":"2017","unstructured":"Kulkantrakorn, K. & Sukphulloprat, P. Outcome of Guillain-Barr\u00e9 Syndrome in Tertiary Care Centers in Thailand. J. Clin. Neuromuscul. Dis. 19, 51\u201356 (2017).","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"1919_CR20","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1440-1754.2008.01325.x","volume":"44","author":"JH Lee","year":"2008","unstructured":"Lee, J. H., Sung, I. Y. & Rew, I. S. Clinical Presentation and Prognosis of Childhood Guillain-Barr\u00e9 Syndrome. J. Paediatr. Child Health 44, 449\u2013454 (2008).","journal-title":"J. Paediatr. Child Health"},{"key":"1919_CR21","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","volume":"366","author":"RA Hughes","year":"2005","unstructured":"Hughes, R. A. & Cornblath, D. R. Guillain-Barr\u00e9 Syndrome. Lancet 366, 1653\u20131666 (2005).","journal-title":"Lancet"},{"key":"1919_CR22","first-page":"199","volume":"55","author":"B Konu\u015fkan","year":"2018","unstructured":"Konu\u015fkan, B., Okuyaz, \u00c7., Ta\u015fdelen, B., Kurul, S. H. & Anlar, B. Electrophysiological Subtypes and Prognostic Factors of Childhood Guillain-Barr\u00e9 Syndrome. Noro Psikiyatr Ars. 55, 199\u2013204 (2018).","journal-title":"Noro Psikiyatr Ars."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01919-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01919-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01919-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T11:11:17Z","timestamp":1669374677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01919-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,15]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1919"],"URL":"https:\/\/doi.org\/10.1038\/s41390-021-01919-3","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,15]]},"assertion":[{"value":"16 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Siriraj Institutional Review Board COA no. 511\/2562(EC3).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}